Home Tags Novartis

Tag: Novartis

Novartis Pays To Settle Exforge Antitrust Suit

Swiss drug company Novartis agreed to pay $245 million to settle a suit claiming it attempted to delay the launch of generic Exforge blood-pressure...

Paris Appeals Court Overturns Novartis, Roche $475M Antitrust Fine

Novartis and Roche won an appeal against a French regulator that had sentenced the two Swiss drugmakers to a record fine over alleged market...

Novartis Settles Antitrust Cases Over Exforge Drug Generics

Novartis AG said it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the...
Novartis

Swiss Competition Watchdog Probes Novartis

The Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss...
Novartis

Novartis Deal May Lead To Cellerys Sale

Novartis has signed a collaboration agreement and option to acquire Cellerys, a Zurich-based startup conducting research on a therapy to fight multiple sclerosis (MS),...
Law

France Fines Novartis, Roche $528M For Anti-Competition Scheme

Novartis and Roche have been fined a collective $528 million by France’s anti-trust regulator for allegedly conspiring to promote the expensive eye disease treatment...
Novartis

Novartis Scraps 1B Asset Sale, Including COVID-19 Treatment To Aurobindo Pharma

Novartis on Thursday, April 2, scrapped the US$1 billion sale of US generic pill and skin drug assets to India's Aurobindo Pharma as regulators...
Novartis

Novartis Exec Pleads Guilty To Price-Fixing

A former senior executive at Novartis AG generics unit Sandoz pleaded guilty on Friday for conspiring to fix prices of generic drugs, the latest...

US: Novartis says price-fixing claims against Sandoz are without merit

Novartis on Monday said claims of price fixing against its Sandoz generics unit amid a US probe of 20 drugmakers are without merit, with...

US: Novartis win antitrust appeal

According to a report from Reuters, a federal appeals court on Tuesday, August 21, upheld the dismissal of two proposed class actions alleging that...
Enable Notifications    OK No thanks